參考文獻(xiàn)/References:
[1] Green M F.Impact of cognitive and social cognitive impairment on functional outcomes in patients with schizophrenia[J].J Clin Psychiatry,2016,77(suppl 2):8-11.
[2] Pirnia T,Woods R P,Hamilton L S,et al.Hippocampal dysfunction during declarative memory encoding in schizophrenia and effects of genetic liability [J].Schizopr Res,2015,161(2/3):357-366.
[3] Chevaleyre V,Piskorowski R A.Hippocampal area CA2:an overlooked but promising therapeutic target[J].Trends Mol Med,2016,22(8):645-655.
[4] Tuulio-Henriksson A, Per l J, Saarni S I,et al.Cognitive functioning in severe psychiatric disorders: a general population study [J].Eur Arch Psychiatry Clin Neurosci,2011,261(6):447-456.
[5] 張明園,何燕玲.最新醫(yī)院精神科量表實(shí)用全書[M].北京:人民衛(wèi)生出版社,2015:113.
[6] 司天梅.精神分裂癥早期干預(yù)的研究進(jìn)展及挑戰(zhàn)[J].中華精神科雜志,2016,49(6):349-352.
[7] Boudewyn M A.Undersdanding working memory and attentional control impairments in schizophrenia[J].Biol Psychiatry Cogn Neurosci Neuroimaging,2017,2(3):212-213.
[8] 馬顯明,韓國(guó)玲.主動(dòng)性社區(qū)治療對(duì)老年精神分裂癥患者社會(huì)功能恢復(fù)的影響[J].中華保健醫(yī)學(xué)雜志,2018,20(6):461-463.
[9] Koshiyanma D.Fukunaga M,Okada N,et al.Subcortical association with memory performance in schizophrenia: a structural magnetic resonance imaging study[J].Transl Psychiatry,2018,8(1):20.
[10] Bonsod A,Sonavane S S,Shah N B,et al.A randomized,conblind,naturalistic comparison of efficacy and cognitive outcomes with right unilateral,bifrontal,and bilemporal electroconvulsive therapy in schizophrenia[J].J ECT,2018,34(1):26-30.
[11] 姚雪峰,趙洪洋,常會(huì)民.慢性精神分裂癥患者雙側(cè)海馬質(zhì)子磁共振波譜成像研究[J].中華神經(jīng)醫(yī)學(xué)雜志,2010,9(2):162-166.
[12] 劉春龍,瞿鵬.長(zhǎng)期服用奧氮平對(duì)130例精神分裂癥患者糖脂代謝及內(nèi)分泌的影響[J].上海醫(yī)藥,2020,41(5):40-42.
[13] Yoshimura Y,Takeda T,Kishi Y,et al.Optimal dosing of risperidone and olanzapine in the maintenance treatment for patients with schizophrenia and related psychotic disorders: a retrospective multicenter study[J].J Clin Psychophamacol,2017,37(3):296-301.
[14] Vacllamani L N,Banwari G,Dinakarau D,el al.Olanzapine has poorer efficacy than risperidone for the treatment of the negative symptoms of schizophrenia [J].India J Psychiatry,2017,59(2):248-249.